EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study

Vimal Mehta, Nikhil Agarwal, Pratishtha Mehra, Navya Mehta, Jamal Yusuf, Pradeep Kumar Dabla, Sana Sukhija, Safal Safal, Mohit Gupta, Surendra Kumar, Sanjeev Kathuria, Akhilesh Kumar und 3 weitere

Journal of The Association of Physicians of India · 2026-03 · 74 (3) · 68-74

DOI: 10.59556/japi.74.1444 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of The Association of Physicians of India, 2026-03. Verfasst von Vimal Mehta und 14 weiteren Autor:innen. Beteiligte Einrichtung: Director-Professor, Department of Cardiology, GB Pant Institute of Postgraduate Medical Education and Research, Faridabad, Haryana, India, Correspond…. Hauptthemen laut MEDLINE: Atorvastatin, Acute Coronary Syndrome, Ezetimibe, Anticholesteremic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtorvastatinAcute Coronary SyndromeEzetimibeAnticholesteremic AgentsCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsHumansDrug Therapy, CombinationFemaleMiddle AgedMaleTreatment OutcomeAged

Substanzen

AtorvastatinEzetimibeAnticholesteremic AgentsCholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Director-Professor, Department of Cardiology, GB Pant Institute of Postgraduate Medical Education and Research, Faridabad, Haryana, India, Corresponding Author.
  • GB Pant Institute of Postgraduate Medical Education and Research, Faridabad, Haryana, India.
  • Amrita School of Medicine, Faridabad, Haryana, India.
  • Ohio State University, Columbus, Ohio, USA.
  • Yashoda Superspeciality Hospital, Kaushambi, Uttar Pradesh, India.
  • Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.

Zitieren

APA

Mehta, V., Agarwal, N., Mehra, P., Mehta, N., Yusuf, J., Dabla, P. K., Sukhija, S., Safal, S., Gupta, M., Kumar, S., Kathuria, S., Kumar, A., Duell, P. B., Pareek, K. K., & Puri, R. (2026). Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study. Journal of The Association of Physicians of India, 74(3), 68-74. https://doi.org/10.59556/japi.74.1444

Vancouver

Mehta V, Agarwal N, Mehra P, Mehta N, Yusuf J, Dabla PK, et al. Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study. Journal of The Association of Physicians of India. 2026;74(3):68-74. doi:10.59556/japi.74.1444

BibTeX
@article{Mehta2026,
  author = {Mehta, Vimal and Agarwal, Nikhil and Mehra, Pratishtha and Mehta, Navya and Yusuf, Jamal and Dabla, Pradeep Kumar and Sukhija, Sana and Safal, Safal and Gupta, Mohit and Kumar, Surendra and Kathuria, Sanjeev and Kumar, Akhilesh and Duell, P Barton and Pareek, K K and Puri, Raman},
  title = {Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study},
  journal = {Journal of The Association of Physicians of India},
  year = {2026},
  volume = {74},
  number = {3},
  pages = {68--74},
  doi = {10.59556/japi.74.1444}
}
Kostenlos starten →